跳至主要内容
临床试验/NCT02508220
NCT02508220已完成不适用

Short-term Effects of Oxytocin Nasal Spray on Chronic Tinnitus

Berthold Langguth, MD, Ph.D.0 个研究点目标入组 15 人开始时间: 2015年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
15
主要终点
Change of Clinical global impression scale

研究概览

简要总结

The study compares the short-term tinnitus reduction following a single oxytocin intervention with a placebo control condition.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • chronic tinnitus with a duration > 6 months
  • medical examination by an ENT specialist
  • sufficient knowledge of the Portuguese language to follow the instructions and answer the questionnaires
  • VAS score >4 points

排除标准

  • vascular tinnitus
  • muscular tinnitus
  • conductive hearing loss
  • previous experience with oxytocin nasal spray
  • additional medications during the intervention

研究组 & 干预措施

Oxy-Placebo

Other

Syntocinon first, Placebo second 2 puffs in each nostril

干预措施: Syntocinon (Drug)

Oxy-Placebo

Other

Syntocinon first, Placebo second 2 puffs in each nostril

干预措施: Placebo (Drug)

Placebo-Oxy

Other

Placebo first, Syntocinon second 2 puffs in each nostril

干预措施: Syntocinon (Drug)

Placebo-Oxy

Other

Placebo first, Syntocinon second 2 puffs in each nostril

干预措施: Placebo (Drug)

结局指标

主要结局

Change of Clinical global impression scale

时间窗: 30 minutes after intervention

Change of tinnitus on VAS

时间窗: 30 minutes after intervention

次要结局

  • Tinnitus Matching(within one hour before intervention)
  • Minimum Masking Level measured in dB HL(within one hour before intervention)
  • Audiometry measured in dB HL(within one hour before intervention)

研究者

发起方
Berthold Langguth, MD, Ph.D.
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Berthold Langguth, MD, Ph.D.

Chair of the Tinnitus centrum Regensburg

University of Regensburg

相似试验